RI H7116 | 2022 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on January 20 2022 - 25% progression, died in committee
Action: 2022-02-01 - Committee recommended measure be held for further study
Pending: House Corporations Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 20 2022 - 25% progression, died in committee
Action: 2022-02-01 - Committee recommended measure be held for further study
Pending: House Corporations Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Directs the state board of pharmacy to annually identify up to fifteen prescription drugs with increased costs and provide the list to the attorney general to obtain reasons for the cost increases.
Title
Pharmaceutical Cost Transparency
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2022-02-01 | House | Committee recommended measure be held for further study |
| 2022-01-28 | House | Scheduled for hearing and/or consideration (02/01/2022) |
| 2022-01-20 | House | Introduced, referred to House Corporations |
Rhode Island State Sources
| Type | Source |
|---|---|
| Summary | https://status.rilegislature.gov/ |
| Text | https://webserver.rilegislature.gov/BillText22/HouseText22/H7116.pdf |
